Home Physical Sciences The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3
Article Open Access

The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3

  • Hui P. Wang , Juan Xu , Li F. Ning , Peng Li and Xiao F. Chen EMAIL logo
Published/Copyright: January 29, 2018
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 233 Issue 2

Abstract

C19H27NO3, orthorhombic, P212121 (no. 19), a = 8.1564(16) Å, b = 16.937(3) Å, c = 24.686(10) Å, V = 3410.3(12) Å3, Z = 8, Rgt(F) = 0.0651, wRref(F2) = 0.1345, T = 153(2) K.

CCDC no.:: 1561687

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Block, colorless
Size:0.21 × 0.20 × 0.160 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.08 mm−1
Diffractometer, scan mode:R-AXIS IV, φ and ω-scans
2θmax, completeness:27.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:14062, 7705, 0.041
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 7043
N(param)refined:417
Programs:CrystalClear [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.1666(3)0.42724(18)0.70762(10)0.0375(7)
H10.21010.39380.72820.045*
O20.5540(3)0.34734(17)0.28128(10)0.0352(6)
H20.45910.33350.27210.042*
C10.2222(4)0.4127(2)0.65534(15)0.0286(8)
C20.1099(4)0.4113(2)0.61337(15)0.0299(8)
H2A−0.00260.42200.62000.036*
C30.1642(4)0.3939(2)0.56140(14)0.0269(8)
H30.08640.39220.53280.032*
C40.3288(4)0.3787(2)0.54957(14)0.0223(7)
C50.4412(4)0.3836(2)0.59240(14)0.0232(7)
C60.3864(4)0.4002(2)0.64469(14)0.0258(7)
H60.46340.40290.67350.031*
C70.6230(4)0.3732(2)0.58389(13)0.0255(7)
H7A0.66680.33920.61310.031*
H7B0.67700.42530.58690.031*
C80.6679(4)0.3367(2)0.52940(14)0.0246(7)
H8A0.78560.34620.52210.030*
H8B0.65060.27890.53110.030*
C90.5666(4)0.3707(2)0.48323(13)0.0209(7)
H90.58210.42920.48210.025*
C100.3842(4)0.3522(2)0.49354(14)0.0215(7)
H100.37550.29330.49360.026*
C110.2741(4)0.3804(2)0.44686(14)0.0260(7)
H11A0.27430.43880.44590.031*
H11B0.16030.36280.45370.031*
C120.3303(4)0.3489(2)0.39144(14)0.0273(8)
H12A0.31320.29100.39010.033*
H12B0.26290.37310.36250.033*
C130.5113(4)0.3671(2)0.38102(14)0.0229(7)
C140.6135(4)0.3359(2)0.42859(14)0.0233(7)
H140.58810.27820.43110.028*
C150.7918(4)0.3411(2)0.40810(14)0.0270(8)
H15A0.86100.29990.42510.032*
H15B0.83960.39360.41590.032*
C160.7767(4)0.3273(2)0.34592(15)0.0316(8)
H16A0.82390.37220.32560.038*
H16B0.83430.27830.33510.038*
C170.5914(4)0.3202(2)0.33516(14)0.0269(8)
H170.55840.26350.33840.032*
C180.5353(4)0.4560(2)0.37116(15)0.0287(8)
H18A0.49420.48570.40240.043*
H18B0.47490.47180.33860.043*
H18C0.65220.46720.36620.043*
O3−0.2784(3)0.62577(16)0.70504(10)0.0306(6)
H3A−0.20490.63550.72790.037*
O40.1323(3)0.63468(16)0.28115(9)0.0308(6)
H40.04690.60880.27440.037*
C19−0.0458(4)0.6299(2)0.64439(14)0.0257(7)
H190.02360.64690.67300.031*
C20−0.2094(4)0.6148(2)0.65495(14)0.0235(7)
C21−0.3103(4)0.5888(2)0.61324(15)0.0280(8)
H21−0.42240.57700.61990.034*
C22−0.2447(4)0.5802(2)0.56165(15)0.0263(7)
H22−0.31470.56340.53310.032*
C23−0.0802(4)0.5951(2)0.54997(14)0.0234(7)
C240.0188(4)0.6208(2)0.59268(14)0.0248(7)
C250.1959(5)0.6452(3)0.58398(15)0.0387(10)
H25A0.26440.61990.61220.046*
H25B0.20460.70310.58880.046*
C260.2648(4)0.6235(3)0.52854(14)0.0311(8)
H26A0.36430.65540.52130.037*
H26B0.29670.56710.52840.037*
C270.1390(4)0.6384(2)0.48406(13)0.0222(7)
H270.10130.69440.48630.027*
C28−0.0096(4)0.5834(2)0.49332(14)0.0240(7)
H280.03400.52820.49230.029*
C29−0.1364(4)0.5890(2)0.44789(14)0.0299(8)
H29A−0.18820.64190.44880.036*
H29B−0.22330.54920.45400.036*
C30−0.0595(5)0.5755(2)0.39185(14)0.0284(8)
H30A−0.01870.52060.38940.034*
H30B−0.14400.58290.36350.034*
C310.0812(4)0.6324(2)0.38191(14)0.0228(7)
C320.2079(4)0.6232(2)0.42772(13)0.0227(7)
H320.24170.56650.42730.027*
C330.3568(4)0.6699(2)0.40763(14)0.0300(8)
H33A0.45950.64920.42370.036*
H33B0.34630.72660.41670.036*
C340.3542(4)0.6570(2)0.34542(14)0.0284(8)
H34A0.35640.70820.32610.034*
H34B0.44980.62520.33380.034*
C350.1938(4)0.6129(2)0.33388(14)0.0257(7)
H350.21660.55490.33400.031*
C360.0172(5)0.7170(2)0.37607(15)0.0308(8)
H36A−0.02090.73610.41140.046*
H36B−0.07390.71790.35020.046*
H36C0.10560.75120.36290.046*
O50.2418(3)0.70941(16)0.74885(12)0.0366(6)
N10.3742(4)0.5928(2)0.73897(14)0.0397(8)
H1A0.28550.56540.74070.048*
H1B0.46710.56950.73490.048*
C370.3681(5)0.6702(2)0.74304(15)0.0305(8)
H370.46890.69820.74140.037*
O60.6207(3)0.45873(17)0.75526(12)0.0374(7)
N20.8359(4)0.3778(2)0.73670(13)0.0356(8)
H2B0.78190.33500.74250.043*
H2C0.93720.37550.72720.043*
C380.7644(5)0.4469(2)0.74186(15)0.0315(8)
H380.82960.49220.73460.038*

Source of material

(17b)-estra-1,3,5(10)-triene-3,17diol (formamide) solvate is easily available. (17b)-estra-1,3,5(10)-triene-3,17diol (50 mg) was dissolved in tetrahydrofuran (2 mL) at 50 °C, then 1 mL formamide was added to the above solution dropwise slowly. The solution was cooled at room temperature and then crystallized using a cold chamber for 3 days. Stirred and filtered to get the (17b)-estra-1,3,5(10)-triene-3,17diol(formamide) solvate.

Experimental details

Hydrogen atoms were obtained geometrically and treated as riding on the parent atoms or were constrained in the locations during refinements.

Discussion

(17b)-estra-1,3,5(10)-triene-3,17diol(estradiol) (systematic name: (8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol is a member of the estrogen family of hormones, which was widespread used in hormonal replacement therapy for the treatment of postmenopausal symptoms and the protection against long-term consequences of estrogen deficiency (osteoporosis and cardiovascular disease) [3, 4] . Polymorphism, which is produced when compound crystallizes in various solid phases that differ in crystal packing [5], [6], [7]. Polymorphs can have different mechanical, thermal, physical, and chemical properties, such as compressibility, melting point, crystal habit, color, density, dissolution rate, and solubility. These can have a great influence on the bioavailability, hygroscopicity, stability, filtration, and tableting processes of pharmaceutical materials [8, 9] . Drug crystallization has been reported in many transdermal matrix systems [10, 11] . Due to the low solubility of estradiol [12], supersaturated patches containing high drug concentrations are often required for obtaining sufficient therapeutic efficiency. Recent work on the crystallization of estradiol in transdermal patches has revealed that the drug possibly crystallizes in more than one polymorphic form in the patch when stored for extended periods of time [13]. So it would thus appear important to anticipate conditions that give rise to crystallization, the structure of the resulting crystals and, when necessary, possible ways of inhibiting crystallization. In the study on polymorphism of estradiol, we got the title solvate of the estradiol with formamide.

The asymmetric unit of the title contains two crystallographically independent molecules of estradiol and two formamide solvent molecules. The estradiol and formamide molecules are hydrogen-bonded via N—H⋯O and O—H⋯O bonds. These connections lead to a hydrogen bonded framework. Bond lengths and angels of all moieties are in the expected ranges.

Acknowledgements

Our research is supported by Key national research and development programmes (No. 2016YFC1000901).

References

Rigaku/MSC: CrystalClear. Rigaku/MSC Inc., The Woodlands, TX, USA (2006).Search in Google Scholar

Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar

Kraemer, G. R.; Kraemer, R. R.; Ogden, B. W.; Kilpatrick, R. E.; Gimpel, T. L.; Castracane, V. D.: Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin. Fertil. Steril. 79 (2003) 534–542.10.1016/S0015-0282(02)04755-6Search in Google Scholar

Ma, X.; Taw, J.; Chiang, C. M.: Control of drug crystallization in transdermal matrix system. Int. J. Pharm. 142 (1996) 115–118.10.1016/0378-5173(96)04647-9Search in Google Scholar

Desiraju, G.: Crystal engineering: the design of organic solids. (1989).Search in Google Scholar

Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.: An extraordinary example of conformational polymorphism. Pharm. Res. 18 (2001) 859–866.10.1023/A:1011052932607Search in Google Scholar

Price, S. L.: The computational prediction of pharmaceutical crystal structures and polymorphism. Adv. Drug Deliv. Rev. 56 (2004) 301–319.10.1016/j.addr.2003.10.006Search in Google Scholar

Ferrari, E. S.; Davey R. J.: Solution-mediated transformation of L-glutamic acid: rate enhancement due to secondary nucleation. Cryst. Growth Des. 4 (2004) 1061–1068.10.1021/cg0342112Search in Google Scholar

Qu, H. Y.; Alatalo, H.; Hatakka, H.; Kohonen, J.: Raman and ATR-FTIR spectroscopy in reactive crystallization: Simultaneous monitoring of solute concentration and polymorphic state of the crystals. J. Cryst. Growth. 311 (2009) 3466–3475.10.1016/j.jcrysgro.2009.04.018Search in Google Scholar

An, J. H.; Choi, G. J.; Kim, W.: Polymorphic and kinetic investigation of adefovir dipivoxil during phase transformation. Int. J. Pharm. 422 (2012) 185–193.10.1016/j.ijpharm.2011.10.049Search in Google Scholar

Variankaval, N. E.; Jacob, K. I.; Din, S. M.: Characterization of crystal forms of estradiol thermal analysis, Raman microscopy, X-ray analysis and solid-state NMR. J. Crystal Growth. 217 (2000) 320–331.10.1016/S0022-0248(00)00442-5Search in Google Scholar

Bak, A.; Gore, A.; Yanez, E.: The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. J. Pharm. Sci-Us. 97 (2008) 3942–3956.10.1002/jps.21280Search in Google Scholar PubMed

Variankaval, N. E.; Jacob, K. I.; Dinh, S. M.: Crystallization of betaestradiol in an acrylic transdermal drug delivery system. J. Biomed. Mater. Res. 44 (1999) 397C–406.10.1002/(SICI)1097-4636(19990315)44:4<397::AID-JBM5>3.0.CO;2-QSearch in Google Scholar

Received: 2017-8-25
Accepted: 2017-12-12
Published Online: 2018-1-29
Published in Print: 2018-3-28

©2018 Hui P. Wang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure and optical properties of diaqua-tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(p-pyridyl)imidazoline-1-oxyl 3-oxide-κN)praseodymium(III), C24H36N9O15Pr
  3. Crystal structure of dimethanol-bis(μ2-methanol-κ2O:O)-bis{3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}dimanganese(II), C38H38Mn2N2O14
  4. Crystal structure of catena-poly[diaqua-bis(μ2-2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ3O,O′:O′)calcium(II)], C56H48N4Ca2Cl8O12
  5. Crystal structure of catena-poly[triaqua-(isophthalato-κO)-(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)]nickel(II), C20H28N4NiO7
  6. Crystal structure of cyclo[hexaqua-bis[1-[(2-ethyl-1H-imidazol-1-yl) methyl]-1H-benzotriazole-κ2N:N′]-bis(sulfato-κ1O)dicadmium(II)] monohydrate, C24H42Cd2N10O16S2
  7. Crystal Structure of bis(2-fluorbenzoato-κO)-bis(1,10-phenanthroline-κ2N,N′)manganese(II) dihydrate, C38H28F2MnN4O6
  8. Crystal structure of tetrapropylammonium 5-hydroxyisophthalate tetrahydrate, C20H41NO9
  9. Crystal structural of 2-amino-4-(3-bromophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran, C18H17BrN2O2
  10. Crystal structural of 2-amino-4-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H16N2O3
  11. Crystal structure of catena-poly[aqua(μ2-1,3-bis(1H-benzo[d]imidazol-1-yl)propane-κ2N:N′)-(μ2-5-(tert-butyl)isophthalate-κ3O,O′:O′′)nickel(II)], C29H30N4NiO5
  12. Crystal structure of catena-poly[(μ2-dicyanamido-κ2N:N′)-(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O′)copper(II)], C9H8CuN4O
  13. Crystal structure of bis(5,5′-((butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido-k4N,N′,N′′,N′′′)copper(II), C24H32CuN4O4
  14. The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3
  15. Crystal structure of catena-poly[diaqua-bis(μ2-1H-benzo[d]imidazole-5-carboxylato-κ2N:O)nickel(II)] dihydrate, C16H18N4NiO8
  16. Crystal structure of dibromido[(1,2-bis(diisopropylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]nickel(II), C14H38B10NiBr2P2
  17. The crystal structure of catena-poly[aquachlorido(3,3′-([4,4′-bipyridine]-1,1′-diium-1,1′-diylbis(methylene))dibenzoato-κ2O:O′)copper(II)] chloride dihydrate, C26H26Cl2CuN2O7
  18. The crystal structure of N′-(2-nitrobenzylidene)-2-phenylacetohydrazide, C15H13N3O3
  19. Crystal structure of dichlorido bis[1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κ1N]cadmium(II), C30H26CdCl2N10
  20. Crystal structure of aqua-bis(3-(2-pyridyl)-5-(4-pyridyl)-1H-1,2,4-triazole-κ2N,N′)copper(II) sulfate tetrahydrate, C24H28CuN10O9S
  21. Crystal structure of dibromido-carbonyl-(η6-p-cymene)osmium(II), C11H14Br2OOs
  22. Crystal structure of catena-poly[chlorido-(μ2-chlorido)-bis(imidazole-κN)copper(II)] C6H8Cl2CuN4
  23. Crystal structure of [(1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]dibromidonickel(II)), C26H54B10NiBr2P2
  24. Crystal structure of dichlorido[1,1′-bis(diphenylphosphanyl)ferrocene-κ2P,P′]zinc(II), C34H28FeCl2P2Zn
  25. Crystal structure of tris(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O)-trithiocyanato-κN-dicobalt(III), C24H24Co2N6O3S3
  26. The crystal structure of diaqua-2,2′-((cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))diphenolato-κ4N,N′,O,O′)manganese(III) perchlorate, C20H24MnClN2O4
  27. Crystal structure of bis(μ3-chlorido)-bis(μ2-chlorido)-tetrakis(μ2-2,6-bis (diphenylmethyl)-4-t-butylphenolato)tetralithium(I)dicobalt(II) toluene solvate, C75.5H70Cl2CoLi2O2
  28. The crystal structure of hexaaqua-bis(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O:O′)-tetrakis(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)dierbium(III) octahydrate, C60H76N18O32Er2
  29. Crystal structure of dimethylammonium bis(naphthalene-2,3-diolato)borate, C22H20BNO4
  30. Crystal structure of 2-amino-4-(4-nitro-phenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H17N3O4
  31. The crystal structure of (E)-4-chloro-2-(((5-methylpyridin-2-yl)imino)methyl)phenol, C13H11ClN2O
  32. Crystal structure of bis(N,N,N-trimethylbutanaminium) poly[heptaselenidotristannate(IV)], C14H36N2Se7Sn3
  33. The crystal structure of N-((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)-4-methylbenzenesulfonamide, C28H35N3S
  34. Crystal structure of 2-(4-chlorophenyl)-2,3-dihydro-1H-perimidine, C17H13Cl1N2
  35. The Crystal structure of 2-iodo-1-(p-tolyl)propan-1-one, C10H11IO
  36. Crystal structure of ethyl 1-(4-bromobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17BrN2O2
  37. Crystal structure of ethyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17FN2O2
  38. Crystal structure of catena-poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C8H8O8Cd
  39. Crystal structure of tetraaqua-bis[6-(1H-imidazol-1-yl-κN)nicotinato]zinc(II), C18H20N6O8Zn
  40. Crystal structure of dichlorido-bis(N-phenyl-2-(quinolin-8-yloxy)acetamide-κ2N,O) – acetone (2/1), C35.5H31N4O4.5Cl2Cu
  41. Crystal Structure of ethyl (E)-3,4-dimethyl-5-((2-(4-methylbenzoyl)hydrazono)methyl)-1H-pyrrole-2-carboxylate — water — ethanol (1/1/1), C20H29N3O5
  42. Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S
  43. The crystal structure of a matrine derivative: 41S,7aS,12S,13aR,13bR)-12-(4-methylpiperazin-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one, C20H34N4O
  44. Crystal structure of cesium beryllophosphate, Be3Cs2P4O14
  45. Crystal Structure of 3-((3-hydroxybenzyl)ammonio)-3-phenylpropanoate, C16H17NO3
  46. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride — 4-hydroxy-3-methoxybenzoic acid — water (2/1/5), C48H54N2Cl2O17
  47. The crystal structure of (1R, 2R)-N1,N2-diferrocenyl-1,2-cyclohexanedicarboxamide, C28H30Fe2N2O2
  48. Crystal structure of N-(2-methylphenyl)ethoxycarbothioamide, C10H13NOS
  49. Crystal Structure of ethyl (E)-2,4-dimethyl-5-((2-tosylhydrazono)methyl)-1H-pyrrole-3-carboxylate monohydrate, C17H23N3O5
  50. Crystal structure of Diiodo-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3N,N′,O)cadium(II) – dimethylformamide (1/1), C19H19N5O2CdI2
  51. Crystal structure of dinitrato-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3-N,N′,O)copper(II), C16H12N6O7Cu
  52. Crystal structure of benzoato-κO-bis(1,3,5-triaza-7-phosphaadamantane-κP)silver(I) monohydrate C19H31AgN6O3P2
  53. Crystal structure of (E)-2-(anthracen-9-ylmethylene)hydrazine-1-carbothioamide, C16H13N3S
  54. The crystal structure of 8-chloro-7-ethyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, C9H11ClN4O2
  55. Crystal structure of {5,5′-((propane-1,3-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′}zinc(II), C23H30N4O4Cu
  56. Crystal structure of bis(4-dimethylamino-pyridin-1-ium)tetrafluorosuccinate, C18H22F4N4O4
  57. Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4
  58. Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6
  59. Crystal structure of bis(acetato-κO)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)nickel(II), C18H22N4NiO6
  60. Crystal structure of (N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3N,O,O′)-diphenyltin(IV), C28H23FN2O3Sn
  61. Crystal structure of {N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3O,N,O′}dimethyltin(IV), C18H19FN2O3Sn
https://doi.org/10.1515/ncrs-2017-0198
Creative Commons
BY-NC-ND 4.0

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure and optical properties of diaqua-tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(p-pyridyl)imidazoline-1-oxyl 3-oxide-κN)praseodymium(III), C24H36N9O15Pr
  3. Crystal structure of dimethanol-bis(μ2-methanol-κ2O:O)-bis{3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}dimanganese(II), C38H38Mn2N2O14
  4. Crystal structure of catena-poly[diaqua-bis(μ2-2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ3O,O′:O′)calcium(II)], C56H48N4Ca2Cl8O12
  5. Crystal structure of catena-poly[triaqua-(isophthalato-κO)-(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)]nickel(II), C20H28N4NiO7
  6. Crystal structure of cyclo[hexaqua-bis[1-[(2-ethyl-1H-imidazol-1-yl) methyl]-1H-benzotriazole-κ2N:N′]-bis(sulfato-κ1O)dicadmium(II)] monohydrate, C24H42Cd2N10O16S2
  7. Crystal Structure of bis(2-fluorbenzoato-κO)-bis(1,10-phenanthroline-κ2N,N′)manganese(II) dihydrate, C38H28F2MnN4O6
  8. Crystal structure of tetrapropylammonium 5-hydroxyisophthalate tetrahydrate, C20H41NO9
  9. Crystal structural of 2-amino-4-(3-bromophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran, C18H17BrN2O2
  10. Crystal structural of 2-amino-4-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H16N2O3
  11. Crystal structure of catena-poly[aqua(μ2-1,3-bis(1H-benzo[d]imidazol-1-yl)propane-κ2N:N′)-(μ2-5-(tert-butyl)isophthalate-κ3O,O′:O′′)nickel(II)], C29H30N4NiO5
  12. Crystal structure of catena-poly[(μ2-dicyanamido-κ2N:N′)-(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O′)copper(II)], C9H8CuN4O
  13. Crystal structure of bis(5,5′-((butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido-k4N,N′,N′′,N′′′)copper(II), C24H32CuN4O4
  14. The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3
  15. Crystal structure of catena-poly[diaqua-bis(μ2-1H-benzo[d]imidazole-5-carboxylato-κ2N:O)nickel(II)] dihydrate, C16H18N4NiO8
  16. Crystal structure of dibromido[(1,2-bis(diisopropylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]nickel(II), C14H38B10NiBr2P2
  17. The crystal structure of catena-poly[aquachlorido(3,3′-([4,4′-bipyridine]-1,1′-diium-1,1′-diylbis(methylene))dibenzoato-κ2O:O′)copper(II)] chloride dihydrate, C26H26Cl2CuN2O7
  18. The crystal structure of N′-(2-nitrobenzylidene)-2-phenylacetohydrazide, C15H13N3O3
  19. Crystal structure of dichlorido bis[1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κ1N]cadmium(II), C30H26CdCl2N10
  20. Crystal structure of aqua-bis(3-(2-pyridyl)-5-(4-pyridyl)-1H-1,2,4-triazole-κ2N,N′)copper(II) sulfate tetrahydrate, C24H28CuN10O9S
  21. Crystal structure of dibromido-carbonyl-(η6-p-cymene)osmium(II), C11H14Br2OOs
  22. Crystal structure of catena-poly[chlorido-(μ2-chlorido)-bis(imidazole-κN)copper(II)] C6H8Cl2CuN4
  23. Crystal structure of [(1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]dibromidonickel(II)), C26H54B10NiBr2P2
  24. Crystal structure of dichlorido[1,1′-bis(diphenylphosphanyl)ferrocene-κ2P,P′]zinc(II), C34H28FeCl2P2Zn
  25. Crystal structure of tris(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O)-trithiocyanato-κN-dicobalt(III), C24H24Co2N6O3S3
  26. The crystal structure of diaqua-2,2′-((cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))diphenolato-κ4N,N′,O,O′)manganese(III) perchlorate, C20H24MnClN2O4
  27. Crystal structure of bis(μ3-chlorido)-bis(μ2-chlorido)-tetrakis(μ2-2,6-bis (diphenylmethyl)-4-t-butylphenolato)tetralithium(I)dicobalt(II) toluene solvate, C75.5H70Cl2CoLi2O2
  28. The crystal structure of hexaaqua-bis(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O:O′)-tetrakis(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)dierbium(III) octahydrate, C60H76N18O32Er2
  29. Crystal structure of dimethylammonium bis(naphthalene-2,3-diolato)borate, C22H20BNO4
  30. Crystal structure of 2-amino-4-(4-nitro-phenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H17N3O4
  31. The crystal structure of (E)-4-chloro-2-(((5-methylpyridin-2-yl)imino)methyl)phenol, C13H11ClN2O
  32. Crystal structure of bis(N,N,N-trimethylbutanaminium) poly[heptaselenidotristannate(IV)], C14H36N2Se7Sn3
  33. The crystal structure of N-((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)-4-methylbenzenesulfonamide, C28H35N3S
  34. Crystal structure of 2-(4-chlorophenyl)-2,3-dihydro-1H-perimidine, C17H13Cl1N2
  35. The Crystal structure of 2-iodo-1-(p-tolyl)propan-1-one, C10H11IO
  36. Crystal structure of ethyl 1-(4-bromobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17BrN2O2
  37. Crystal structure of ethyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17FN2O2
  38. Crystal structure of catena-poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C8H8O8Cd
  39. Crystal structure of tetraaqua-bis[6-(1H-imidazol-1-yl-κN)nicotinato]zinc(II), C18H20N6O8Zn
  40. Crystal structure of dichlorido-bis(N-phenyl-2-(quinolin-8-yloxy)acetamide-κ2N,O) – acetone (2/1), C35.5H31N4O4.5Cl2Cu
  41. Crystal Structure of ethyl (E)-3,4-dimethyl-5-((2-(4-methylbenzoyl)hydrazono)methyl)-1H-pyrrole-2-carboxylate — water — ethanol (1/1/1), C20H29N3O5
  42. Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S
  43. The crystal structure of a matrine derivative: 41S,7aS,12S,13aR,13bR)-12-(4-methylpiperazin-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one, C20H34N4O
  44. Crystal structure of cesium beryllophosphate, Be3Cs2P4O14
  45. Crystal Structure of 3-((3-hydroxybenzyl)ammonio)-3-phenylpropanoate, C16H17NO3
  46. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride — 4-hydroxy-3-methoxybenzoic acid — water (2/1/5), C48H54N2Cl2O17
  47. The crystal structure of (1R, 2R)-N1,N2-diferrocenyl-1,2-cyclohexanedicarboxamide, C28H30Fe2N2O2
  48. Crystal structure of N-(2-methylphenyl)ethoxycarbothioamide, C10H13NOS
  49. Crystal Structure of ethyl (E)-2,4-dimethyl-5-((2-tosylhydrazono)methyl)-1H-pyrrole-3-carboxylate monohydrate, C17H23N3O5
  50. Crystal structure of Diiodo-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3N,N′,O)cadium(II) – dimethylformamide (1/1), C19H19N5O2CdI2
  51. Crystal structure of dinitrato-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3-N,N′,O)copper(II), C16H12N6O7Cu
  52. Crystal structure of benzoato-κO-bis(1,3,5-triaza-7-phosphaadamantane-κP)silver(I) monohydrate C19H31AgN6O3P2
  53. Crystal structure of (E)-2-(anthracen-9-ylmethylene)hydrazine-1-carbothioamide, C16H13N3S
  54. The crystal structure of 8-chloro-7-ethyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, C9H11ClN4O2
  55. Crystal structure of {5,5′-((propane-1,3-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′}zinc(II), C23H30N4O4Cu
  56. Crystal structure of bis(4-dimethylamino-pyridin-1-ium)tetrafluorosuccinate, C18H22F4N4O4
  57. Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4
  58. Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6
  59. Crystal structure of bis(acetato-κO)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)nickel(II), C18H22N4NiO6
  60. Crystal structure of (N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3N,O,O′)-diphenyltin(IV), C28H23FN2O3Sn
  61. Crystal structure of {N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3O,N,O′}dimethyltin(IV), C18H19FN2O3Sn
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Winner of the OpenAthens UX Award 2026
Winner of the OpenAthens UX Award 2026
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 4.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0198/html
Scroll to top button